| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 10.08. | SPAC Inflection Point Acquisition VIII files for a $250 million IPO, targeting technology-enabled businesses | ||
| 10.08. | IPO Winners & Losers: New Stocks Surge, Biotech Booms, and AI Rallies | ||
| 10.08. | SPAC Eaglesky Acquisition files for a $100 million IPO, targeting middle market businesses | ||
| 10.08. | SPAC JATT III Acquisition files for a $60 million IPO, following prior SPAC's deal with Talawar Therapeutics | ||
| 10.08. | Defense tech roll-up Lyntris sets terms for $492 million IPO | ||
| 08.08. | US IPO Week Ahead: Chinese copper foil and last call for the summer IPO market | ||
| 08.08. | US IPO Weekly Recap: August kicks off with flurry of biotech IPOs | ||
| 07.08. | SPAC Danneskjold and Galt Acquisition files for a $150 million IPO, targeting fintech and AI | ||
| 07.08. | Hong Kong-based fit-out provider Zensitive Holding files for a $25 million US IPO | ||
| 07.08. | SPAC Southport Acquisition II files for a $200 million IPO, targeting AI | ||
| 07.08. | SPAC OceanLight Acquisition prices $100 million IPO, led by SPAC veteran Ping Zhang | ||
| 07.08. | SPAC Pinnacle Acquisition prices $200 million IPO, targeting the financial sector | ||
| 07.08. | Latin American ticket platform Ticketplus prices US IPO at $8, the low end of the range | ||
| 07.08. | HydroThermal Reactor power plant developer KiNRG files for a $17 million IPO | ||
| 07.08. | SPAC Lucens Capital Acquisition I files for a $100 million IPO, targeting Argentina | ||
| 07.08. | BlossomHill Therapeutics prices upsized IPO at $16, the midpoint of the range | ||
| 07.08. | Latigo Biotherapeutics prices upsized IPO at $18, the high end of the range | ||
| 07.08. | SPAC Rainier Acquisition files for a $75 million IPO, targeting life sciences | ||
| 06.08. | Hong Kong digital marketing provider Poche Technology ups range to $5 to $7 ahead of $38 million US IPO | ||
| 06.08. | California-based River City Bank prices downsized IPO at $45, below the range | ||
| 06.08. | Cardiovascular diseases biotech Braveheart Bio prices upsized IPO at $18, above the range | ||
| 06.08. | Messaging infrastructure provider Spectral Capital sets terms for $15 million Nasdaq uplisting | ||
| 05.08. | SPAC Gravity Acquisition files for a $250 million IPO, targeting North America, Europe, and Asia | ||
| 05.08. | SPAC TCGX Acquisition prices $75 million IPO, targeting healthcare in Asia | ||
| 05.08. | Immune-focused biotech Attovia Therapeutics prices previously upsized IPO at $17, as expected |